MT Newswires
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
➖
AI Sentiment
Neutral
5/10
- Home
- AUTL
as of 12-05-2025 3:46pm EST
$1.55
$0.03
-1.59%
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Chart Type:
Time Range:
| Founded: | 2014 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | 368.6M | IPO Year: | 2018 |
| Target Price: | $8.33 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $3.11 | Next Earning Date: | 11-12-2025 |
| Revenue: | $51,128,000 | Revenue Growth: | 406.67% |
| Revenue Growth (this year): | 658.11% | Revenue Growth (next year): | 91.34% |
AI-Powered AUTL Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 75.33%
75.33%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Autolus Therapeutics plc News
AUTL Breaking Stock News: Dive into AUTL Ticker-Specific Updates for Smart Investing
MT Newswires
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
➖
AI Sentiment
Neutral
5/10
GlobeNewswire
Autolus Therapeutics Appoints Ryan Richardson to Board of Directors
📈
AI Sentiment
Highly Positive
8/10
Compare AUTL vs Leading Stocks
See how AUTL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AUTL Autolus Therapeutics plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.